Table 4.
Intervention | Number of systematic reviews/meta-analysis, total participants | First author, year | Primary results/findings | Rating the evidence of effectiveness | |
Patients with acute coronary syndrome | |||||
General health education | Six/161 997 patients (Goulding et al, 201051 did not give the total sample size) | Ghisi, 201450 | Knowledge | 91% studies* | Some evidence |
Behaviour | 77%/84%/65% studies* | ||||
Psychosocial indicators | 43% studies* | ||||
Brown, 201337 | Mortality | ||||
MI | |||||
Revascularisations | |||||
Hospitalisations | |||||
HRQoL | |||||
Withdrawals/dropouts | |||||
Healthcare utilisation and costs | |||||
Brown, 201170 | Total mortality | ||||
MI | |||||
CABG | |||||
Hospitalisations | |||||
HRQoL | 63.6% studies* | ||||
Healthcare costs | 40% studies* | ||||
Withdrawal/dropout | |||||
Goulding, 201051 | Beliefs | 30.08% studies* | |||
Secondary outcomes | |||||
Fernandez, 200748 | Smoking | ||||
Cholesterol level | |||||
Multiple risk factor modification | |||||
Kotb, 201459 | All-cause hospitalisation | ||||
All-cause mortality | |||||
Smoking cessation | |||||
Depression | |||||
Systolic blood pressure | |||||
Low-density lipoprotein | |||||
Anxiety | |||||
Psychoeducational interventions | Six/37 883 patients | Barth, 201569 | Abstinence by self-report or validated | Sufficient evidence | |
Dickens, 201345 | Depression | ||||
Aldcroft, 201131 | Smoking cessation | ||||
Physical activity | |||||
Huttunen-Lenz,201056 | Prevalent smoking cessation | ||||
Continuous smoking cessation | |||||
Total mortality | |||||
Barth, 200836 | Abstinence by self-report or validated | ||||
Smoking status | |||||
Barth, 200635 | Abstinence | ||||
Smoking status | |||||
Secondary prevention educational interventions (including Internet-based secondary prevention) | Three/25 154 patients | Devi, 201544 | Mortality | Some evidence | |
Revascularisation | |||||
Total cholesterol | |||||
HDL cholesterol | |||||
Triglycerides | |||||
HRQOL | |||||
Auer, 200834 | All-cause mortality | ||||
Readmission rates | |||||
Reinfarction rates | |||||
Smoking cessation rates | |||||
Clark, 200541 | Mortality | ||||
MI | |||||
Quality of life | Most of the included studies* | ||||
Patients with T2DM | |||||
General health education | Five/2319 patients (Choi et al, 201640; Loveman et al, 200860; Zabaleta et al, 200779 did not give the total sample size) | Choi, 201640 | HbA1c | Some evidence | |
Saffari, 201474 | Glycaemic control | ||||
Duke, 200946 | HbA1c | ||||
BP | |||||
Knowledge, psychosocial outcomes and smoking habits | No data | ||||
Diabetes complications or health service utilisation and cost analysis | No data | ||||
Loveman, 200860 | Diabetic control outcomes | 46.15% studies* | |||
Weight | 66.67% studies* | ||||
Cholesterol or triglycerides | 40.00% studies (+) | ||||
Zabaleta, 200779 | HbA1c | 4.8% studies* | |||
Culturally appropriate health education | Eight/20 622 patients (Ricci-Cabello et al, 201473 and Gucciardi et al, 201352 did not give the total sample size) | Creamer, 201642 | HbA1c | Some evidence | |
HRQoL | |||||
AEs | No AEs | ||||
Ricci-Cabello, 201473 | HbA1c | ||||
Diabetes knowledge | 73.3% studies* | ||||
Behaviours | 75% studies* | ||||
Clinical outcomes | Fasting blood glucose, HbA1c and BP improved in 71%, 59% and 57% of the studies | ||||
Attridge, 201433 | HbA1c | ||||
Knowledge scores | |||||
Clinical outcomes | |||||
Other outcome measures | Showed neutral effects | ||||
Gucciardi, 201352 | HbA1c levels | 3 of 10 studies* | |||
Anthropometrics | 3 of 11 studies* | ||||
Physical activity | One of five studies* | ||||
Diet outcomes | Two of six studies* | ||||
Nam, 201262 | HbA1c level | ||||
Hawthorne, 201054 | HbA1c | ||||
Knowledge scores | |||||
Khunti, 200858 | Knowledge levels | Only one study reporting a significant improvement | |||
Biomedical outcomes | Only one study reporting a significant improvement | ||||
Hawthorne, 200853 | HbA1c | ||||
Knowledge scores | |||||
Other outcome measures | |||||
Lifestyle interventions+behavioural programme | Six/10 440 patients (Huang et al, 201655; Pillay et al, 201571 and Ramadas et al, 201177 did not give the total sample size) | Huang, 201655 | HbA1c | Some evidence | |
BMI | |||||
LDL-c and HDL-c | |||||
Chen, 201539 | HbA1c | ||||
BMI | |||||
SBP | |||||
DBP | |||||
HDL-c | |||||
Terranova, 201572 | HbA1c level | ||||
Weight | |||||
Pillay, 201571 | HbA1c levels | ||||
BMI | |||||
Ramadas, 201177 | HbA1c | 46.2% studies * | |||
Gary, 200349 | Fast blood sugar | ||||
Glycohaemoglobin | |||||
HbA1 | |||||
HbA1c | |||||
Weight | |||||
Self-management educational interventions | Nine/19 597 patients (Minet et al, 201061; Fan et al, 200947 and Norris et al, 200164 did not give the total sample size) | Pal, 201467 | Cardiovascular risk factors | Sufficient evidence | |
Cognitive outcomes | |||||
Behavioural outcomes | Only one study reporting a significant improvement | ||||
AEs | No AEs | ||||
Vugt, 201375 | Health behaviours | 7 of 13 studies * | |||
Clinical outcomes measures | Nine studies * | ||||
Psychological outcomes | Nine studies * | ||||
Pal, 201368 | HbA1c | ||||
Depression | |||||
Quality of life | |||||
Weight | |||||
Steinsbekk, 201276 | HbA1c | ||||
Main lifestyle outcomes | |||||
Main psychosocial outcomes | |||||
Minet, 201061 | Glycaemic control | ||||
Fan, 200947 | Diabetes knowledge | ||||
Overall self-management behaviours | |||||
Overall metabolic outcomes | |||||
Overall weighted mean effect sizes | |||||
Deakin, 200543 | Metabolic control (HbA1c) | ||||
Fasting blood glucose levels | |||||
Weight | |||||
Diabetes knowledge | |||||
SBP | |||||
Diabetes medication | |||||
Norris, 200265 | Total GHb | ||||
Norris, 200164 | Knowledge | ||||
Self-monitoring of blood glucose | |||||
Self-reported dietary habits | |||||
Glycaemic control | |||||
Therapeutic education | One/total sample: unclear | Odnoletkova, 201466 | Cost-effectiveness | Overall high in studies on prediabetes and varied in studies on T2DM | Insufficient evidence |
Foot health education | One/total sample: unclear | Amaeshi32 | Diabetes complications | Some evidence | |
Incidence of LEA | |||||
Group medical visit | One/2240 patients | Burke, 201138 | HbA1c | Some evidence | |
BP and DBP | |||||
SBP | |||||
Cholesterol—LDL | |||||
Psychoeducational intervention | One/1431 patients | Alam, 200930 | HbA1c | Some evidence | |
Psychological status | |||||
Interventions aimed at improving adherence to medical treatment recommendations | Three/4907 patients (Lun Gan et al, 201157 did not give the total sample size) | Lun Gan, 201157 | Oral hypoglycaemic adherence | Five of seven studies * | Some evidence |
Wens et al., 200878 | Adherence | General conclusions could not be drawn | |||
Vermeire, 200580 | HbA1c | ||||
Dietary advice | One/1467 patients | Nield, 200763 | Glycaemic control (addition of exercise to dietary advice) | Insufficient evidence to determine | |
Weight | Limited data | ||||
Diabetic microvascular and macrovascular diseases | Limited data |
*Intervention group is significantly better than control group, for example, ‘91% studies ’ means 91% studies reported a significant better compared with control group.
AEs, adverse events; BMI, body mass index; BP, blood pessure; CABG, coronary artery bypass graft surgery; HbA1c, glycated haemoglobin; HRQoL, health related quality of life; LDL-c, low-density lipoprotein cholesterol; LEA, lower extremity amputation; MI, myocardial infarction; RCTs, randomised controlled trials; SBP, systolic blood pressure, DBP, diastolic blood pressure, HDL-c, high density lipoprotein cholesterol; T2DM, type two diabetes mellitus.